T-wave alternans testing predicts risk of sudden cardiac death – study
This article was originally published in Clinica
Executive Summary
Measuring T-wave alternans (TWA) in addition to heart rate recovery (HRR) can predict a patient's risk of death, a study has found. The findings could lead to new screening programmes to identify patients at low risk of sudden cardiac death who would benefit from antiarrythmic therapy.
You may also be interested in...
Normality Reasserts Itself For Biotech IPOs
The highs of the COVID-19 era, and the lows that supplanted it, are beginning to fade.
MRM Health Pulls A Pouchitis Hit Out Of The Bag
The mid-stage success is encouraging, but taking on Takeda won’t be easy.
Novartis Draws Out Its APPLAUSE
Another data drop from Fabhalta’s IgAN trial looks encouraging, despite a missing abstract.